Fisher Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
83,137
+969
| +1% | +$21K | ﹤0.01% | 590 |
|
|
2025
Q1 | $1.99M | Sell |
82,168
-4,679
| -5% | -$113K | ﹤0.01% | 581 |
|
|
2024
Q4 | $1.81M | Buy |
86,847
+50
| +0.1% | +$1.04K | ﹤0.01% | 593 |
|
|
2024
Q3 | $1.73M | Sell |
86,797
-18,738
| -18% | -$373K | ﹤0.01% | 604 |
|
|
2024
Q2 | $1.63M | Sell |
105,535
-7,084
| -6% | -$110K | ﹤0.01% | 617 |
|
|
2024
Q1 | $1.8M | Buy |
112,619
+955
| +0.9% | +$15.2K | ﹤0.01% | 609 |
|
|
2023
Q4 | $1.88M | Hold |
111,664
| – | – | ﹤0.01% | 599 |
|
|
2023
Q3 | $1.31M | Hold |
111,664
| – | – | ﹤0.01% | 694 |
|
|
2023
Q2 | $1.5M | Hold |
111,664
| – | – | ﹤0.01% | 700 |
|
|
2023
Q1 | $1.85M | Sell |
111,664
-21,904
| -16% | -$363K | ﹤0.01% | 668 |
|
|
2022
Q4 | $2.48M | Sell |
133,568
-157,329
| -54% | -$2.93M | ﹤0.01% | 613 |
|
|
2022
Q3 | $3.73M | Hold |
290,897
| – | – | ﹤0.01% | 491 |
|
|
2022
Q2 | $2.04M | Buy |
290,897
+30,429
| +12% | +$213K | ﹤0.01% | 533 |
|
|
2022
Q1 | $2.16M | Sell |
260,468
-5,084
| -2% | -$42.1K | ﹤0.01% | 541 |
|
|
2021
Q4 | $1.8M | Buy |
265,552
+63,751
| +32% | +$432K | ﹤0.01% | 575 |
|
|
2021
Q3 | $1.07M | Buy |
+201,801
| New | +$1.07M | ﹤0.01% | 607 |
|